This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by POLYCHRONAKOS, C. Articles by POSNER, B.I. Search for Related Content PubMed PubMed Citation Articles by POLYCHRONAKOS, C. Articles by POSNER, B.I.

RECEPTORS FOR THE INSULIN-LIKE GROWTH FACTORS ON HUMAN EKYTHKUUYTES

Departments of Pediatrics and Medicine, McGill University Montreal, Quebec, Canada H3H 1P3

This is publication no. 83024 of the McGill University-Montreal Children’s Hospital Research Institute.

We have examined the presence and properties of specific receptors for the insulin-like growth factors (IGFs) on human erythrocytes (RBC). HPLC purified IGF-I and II peptides were used as ligands. RBCs were separated in density fractions representing cell groups of different ages. Binding to all cell fractions was found for both IGF tracers. Porcine insulin displaced this binding only partially, with a potency that was at least 10 times lower. IGF-II was equipotent with IGF-I in displacing [¹²⁵I] IGF-I binding, but was somewhat more potent than IGF-I in displacing its homologous tracer. In the youngest cell fraction from 7 normal adults, the level of specific binding per 3 x 10⁹ cells was 5.2±0.4% (mean ± SE) and 6.3±0.5% of added radioactivity for IGF-I and IGF-II respectively. It declined rapidly as a function of cell age. Binding for unfractionated cell samples was 2.2±0.1% and 3.1±0.1% respectively. We conclude that: a) Specific receptors for the IGFs exist on human erythrocytes. b) Binding to these receptors is dependent on cell age. c) The binding in isolated young RBCs is of sufficient magnitude to permit their use for the clinical measurement of these receptors.

Received April 29, 1983.

This article has been cited by other articles:

				L. A. Welniak, R. Sun, and W. J. Murphy The role of growth hormone in T-cell development and reconstitution J. Leukoc. Biol., March 1, 2002; 71(3): 381 - 387. [Abstract] [Full Text] [PDF]

				B. Ducos, S. Cabrol, M. Houang, L. Perin, M. Holzenberger, and Y. Le Bouc IGF Type 1 Receptor Ligand Binding Characteristics Are Altered in a Subgroup of Children with Intrauterine Growth Retardation J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5516 - 5524. [Abstract] [Full Text] [PDF]

				O. Mäkitie, E. Juvonen, L. Dunkel, I. Kaitila, and M. A. Siimes Anemia in Children with Cartilage-Hair Hypoplasia Is Related to Body Growth and to the Insulin-Like Growth Factor System J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 563 - 568. [Abstract] [Full Text]

				W. Zumkeller and S. Burdach The Insulin-Like Growth Factor System in Normal and Malignant Hematopoietic Cells Blood, December 1, 1999; 94(11): 3653 - 3657. [Full Text] [PDF]

				Y. Xu, A. Papageorgiou, and C. Polychronakos Developmental Regulation of the Soluble Form of Insulin-Like Growth Factor-II/Mannose 6-Phosphate Receptor in Human Serum and Amniotic Fluid J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 437 - 442. [Abstract] [Full Text]